ЭКЛ Чарльз (GB),ГРЭНДЖ Джон (GB),БИЛЯРД Кевин (GB)
申请号：
RU2016123370
公开号：
RU2016123370A
申请日:
2014.12.16
申请国别(地区):
RU
年份:
2018
代理人:
摘要：
An immunomodulator is for use in the treatment, reduction, inhibition or control of a neoplastic disease in a patient intended to undergo checkpoint inhibition therapy, simultaneously, separately or sequentially with administration of the immunomodulator. The immunomodulator preferably includes a whole cell Mycobacterium, such as M. vaccae or M. obuense.
